推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Novel Glaucoma Procedures:: A Report by the American Academy of Ophthalmology

BA Francis, K Singh, SC Lin, E Hodapp… - Ophthalmology, 2011 - Elsevier
Devices and procedures that have US Food and Drug Administration clearance or are currently
in phase III clinical trials in the United States are included: the Fugo blade (Medisurg Ltd.,
Norristown, PA), Ex-PRESS mini glaucoma shunt (Alcon, Inc., Hunenberg, Switzerland), ...
Related articles - All 2 versions

Assessment of Visual Function in Glaucoma:: A Report by the American Academy of Ophthalmology

HD Jampel, K Singh, SC Lin, TC Chen, BA Francis… - Ophthalmology, 2011 - Elsevier
Literature searches of the PubMed and Cochrane Library databases were conducted last on
May 7, 2010, and were restricted to citations published on or after January 1, 1994. The search
yielded 1063 unique citations. The first author reviewed the titles and abstracts of these ...
Cited by 1 - Related articles - All 3 versions

Deep Anterior Lamellar Keratoplasty as an Alternative to Penetrating Keratoplasty:: A Report by the American Academy of Ophthalmology

[PDF] from assocheratocono.orgWJ Reinhart, DC Musch, DS Jacobs, WB Lee… - Ophthalmology, 2011 - Elsevier
Eleven DALK/PK comparative studies (level II and level III evidence) were identified that compared
the results of DALK and PK procedures directly; they included 481 DALK eyes and 501 PK
eyes. Of those studies reporting vision and refractive data, there was no significant ...
Cited by 4 - Related articles - All 7 versions

Double Fovea Artifact

DE Baskin, JA Gault, JF Vander… - Ophthalmology, 2011 - ophsource.org
Ophthalmology, Volume 118, Issue 2, Pages 429-429.e1, February 2011, Authors:Darrell E. Baskin,
MD; Janice A. Gault, MD; James F. Vander, MD; John D. Dugan, MD. ... « PreviousNext
»Ophthalmology Volume 118, Issue 2 , Pages 429-429.e1, February 2011. ...
Related articles - Cached - All 6 versions

[HTML] The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

[HTML] from ophsource.orgJS Heier, D Boyer, QD Nguyen, D Marcus… - …, 2011 - ophsource.org
Presented at: The Retina Society, October, 2009; American Academy of Ophthalmology Annual
Meeting, October, 2009; International Symposium on Ocular Pharmacology and
Therapeutics, December 2009; Association for Research in Vision and Ophthalmology ...
Cached - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451